Clinical Trial Update: Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer

View source ↗

Summary

A planned clinical trial investigates using a PD-1 monoclonal antibody in combination with interleukin-2 and CapeOX chemotherapy for organ preservation in ultra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• CapeOX chemotherapy (Capecitabine + Oxaliplatin)
• Interleukin-2 (interleukin-2)
• PD-1 monoclonal antibody

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Rectal Cancer | Status: NOT_YET_RECRUITING